Justin A. Rodante
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Justin A. Rodante has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
- Martin Peter Playford
Section of Inflammation and Cardiometabolic Diseases, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA
6 shared publications - Nehal Nikhilesh Mehta
The George Washington University School of Medicine, Washington, D.C., USA
6 shared publications - Alexander V. Sorokin
Section of Inflammation and Cardiometabolic Diseases, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA
4 shared publications - Andrew Keel
Section of Inflammation and Cardiometabolic Diseases, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA
4 shared publications - Heather L. Teague
Critical Care Medicine and Pulmonary Branch, National Heart Lung and Blood Institute, NIH, Bethesda, Maryland, USA
4 shared publications - Joel M. Gelfand
Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Center for Clinical Sciences in Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
4 shared publications
Latest Publications
- Open Access
- 3 November 2023
- Published by Elsevier in JID Innovations
- Vol. 4 (1) , 100243
Circulating Oxidized mtDNA is Associated Broadly with Cardiovascular Disease in a Longitudinal Cohort Study of Psoriasis
- 3 November 2023
- Published by Elsevier in JID Innovations
- Vol. 4 (1) , 100243
Open AccessCirculating Oxidized mtDNA is Associated Broadly with Cardiovascular Disease in a Longitudinal Cohort Study of Psoriasis
- 22 April 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (10) , 1947-1954.e4
The Relationship between Circulating APOA-1 and Atherosclerosis Initiation and Progression in Psoriasis
- 22 April 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (10) , 1947-1954.e4
The Relationship between Circulating APOA-1 and Atherosclerosis Initiation and Progression in Psoriasis
- 1 January 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 142 (1) , 88-96
Subclinical Liver Disease Is Associated with Subclinical Atherosclerosis in Psoriasis: Results from Two Observational Studies
- 1 January 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 142 (1) , 88-96
Subclinical Liver Disease Is Associated with Subclinical Atherosclerosis in Psoriasis: Results from Two Observational Studies
- 1 October 2021
- Published by Elsevier in JACC: Cardiovascular Imaging
- Vol. 14 (10) , 2044-2046
Sex Differences in Subclinical Coronary Atherosclerosis in Psoriasis by Coronary Computed Tomography Angiography
- 1 October 2021
- Published by Elsevier in JACC: Cardiovascular Imaging
- Vol. 14 (10) , 2044-2046
Sex Differences in Subclinical Coronary Atherosclerosis in Psoriasis by Coronary Computed Tomography Angiography
- 1 April 2021
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 141 (4) , 913-916
Impaired Coronary Blood Flow in Patients with Psoriasis: Findings from an Observational Cohort Study
- 1 April 2021
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 141 (4) , 913-916
Impaired Coronary Blood Flow in Patients with Psoriasis: Findings from an Observational Cohort Study
- 11 November 2016
- Published by Wolters Kluwer Health in Circulation
- Vol. 134 (suppl_1)
Abstract 12605: Brain Metabolic Activity Within Regions Involved in Stress Perception Associates Directly With Arterial Inflammation and Inversely With Aortic Distensibility in Psoriasis
Introduction: Psychological stress and depression are linked to increased cardiovascular (CV) events in the general population and in psoriasis (PSO), a chronic inflammatory disease that increases CV risk. 18-FDG-PET/CT enables quantification of metabolic activity of the amygdala, a neural tissue critically involved in the pathobiology of stress and depression. In individuals without chronic inflammatory diseases, amygdalar activity (AmygAct) associates with greater vascular inflammation (VI) and CV events. However, it is not known whether PSO maintains this relationship with VI and whether AmygAct associates with other measures of subclinical CVD. Hypothesis: In PSO, AmygAct: 1) is higher in individuals who report depression/anxiety, and 2) associates with greater VI and decreased aortic distensibility. Methods: Subjects with PSO (n=82) completed a questionnaire at baseline, reporting psychiatric history and were placed into two groups accordingly: patients with depression/anxiety and age and sex matched controls with no psychiatric diagnoses. AmygAct was quantified using 18-FDG PET/CT by an analyst blinded to clinical data. Mean standardized uptake values (SUV) for the left amygdala were corrected for background brain activity. VI was quantified as a ratio of aortic to blood background SUV. Aortic distensibility was measured using phase contrast MRI. Results: Subjects had a mean age of 49.2 years, were 49% males, and had a median Framingham risk score of 3. Patients with a history of depression and/or anxiety had significantly higher AmygAct than those without (mean±SEM 0.85±0.01 vs. 0.81±0.01; p=0.01). AmygAct correlated with VI (β= 0.26, p=0.02) as well as aortic distensibility (β= -0.50, pConclusions: Metabolic activity within neural tissues involved in stress perception significantly associates with indices of atherosclerotic disease in PSO. Future studies should further evaluate the mechanisms linking neural and atherosclerotic tissues in chronic inflammatory conditions such as PSO, and probe whether perturbing this mechanism may reduce the burden of atherosclerosis.
- 11 November 2016
- Published by Wolters Kluwer Health in Circulation
- Vol. 134 (suppl_1)
Abstract 12605: Brain Metabolic Activity Within Regions Involved in Stress Perception Associates Directly With Arterial Inflammation and Inversely With Aortic Distensibility in Psoriasis
Introduction: Psychological stress and depression are linked to increased cardiovascular (CV) events in the general population and in psoriasis (PSO), a chronic inflammatory disease that increases CV risk. 18-FDG-PET/CT enables quantification of metabolic activity of the amygdala, a neural tissue critically involved in the pathobiology of stress and depression. In individuals without chronic inflammatory diseases, amygdalar activity (AmygAct) associates with greater vascular inflammation (VI) and CV events. However, it is not known whether PSO maintains this relationship with VI and whether AmygAct associates with other measures of subclinical CVD. Hypothesis: In PSO, AmygAct: 1) is higher in individuals who report depression/anxiety, and 2) associates with greater VI and decreased aortic distensibility. Methods: Subjects with PSO (n=82) completed a questionnaire at baseline, reporting psychiatric history and were placed into two groups accordingly: patients with depression/anxiety and age and sex matched controls with no psychiatric diagnoses. AmygAct was quantified using 18-FDG PET/CT by an analyst blinded to clinical data. Mean standardized uptake values (SUV) for the left amygdala were corrected for background brain activity. VI was quantified as a ratio of aortic to blood background SUV. Aortic distensibility was measured using phase contrast MRI. Results: Subjects had a mean age of 49.2 years, were 49% males, and had a median Framingham risk score of 3. Patients with a history of depression and/or anxiety had significantly higher AmygAct than those without (mean±SEM 0.85±0.01 vs. 0.81±0.01; p=0.01). AmygAct correlated with VI (β= 0.26, p=0.02) as well as aortic distensibility (β= -0.50, pConclusions: Metabolic activity within neural tissues involved in stress perception significantly associates with indices of atherosclerotic disease in PSO. Future studies should further evaluate the mechanisms linking neural and atherosclerotic tissues in chronic inflammatory conditions such as PSO, and probe whether perturbing this mechanism may reduce the burden of atherosclerosis.